Announcements Trials

Browse Landscape Eligibility

Clinical Trials

0 trials

Recent Start date Enrollment

Primary hyperoxaluria type 2 × Endocrine × 30 days × Clear all

Sponsor

Conditions

Neuroendocrine Tumors 36 Carcinoma, Neuroendocrine 14 Thyroid Neoplasms 13 Pheochromocytoma 12 Thyroid Cancer, Papillary 11 Pituitary Neoplasms 9 Paraganglioma 8 Adrenocortical Carcinoma 8 Neoplasms 7 Adenoma, Islet Cell 7 Neuroblastoma 6 Carcinoma, Non-Small-Cell Lung 6 Sarcoma 5 Parathyroid Neoplasms 5 Multiple Endocrine Neoplasia Type 1 5 Lung Neoplasms 5 Gastro-enteropancreatic neuroendocrine tumor 5 Carcinoma 5 Adrenal Gland Neoplasms 5 Adenocarcinoma, Follicular 5 Thyroid Carcinoma, Anaplastic 4 Small Cell Lung Carcinoma 4 Recurrence 4 Neoplasm Metastasis 4 Mesothelioma 4 Endocrine System Diseases 4 Cholangiocarcinoma 4 Carcinoma, Medullary 4 Carcinoma, Hepatocellular 4 Carcinoid Tumor 4

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

No trials found.

Data powered by HemOnc (CC BY 4.0) Colophon ⚡